Concepedia

Xiaomin Wan

XW

40

Publications

1.1K

Citations

20

H-Index

2009

Active since

Affiliations

Second Xiangya Hospital of Central South University(Current)

Central South University

University of Sheffield

University of Tasmania

Xiaomin Wan is an author at Second Xiangya Hospital of Central South University specializing in medicine, oncology, and cancer therapeutics.

Top concepts

Publications per year

2009–2024

40

Publications

40

First-line Nivolumab Plus Ipilimumab vs Sunitinib for Metastatic Renal Cell Carcinoma

Xiaomin Wan, Yucong Zhang, Chongqing Tan et al. · JAMA Oncology · 2019 · 151 citations · Full text

First‐line atezolizumab in addition to bevacizumab plus chemotherapy for metastatic, nonsquamous non–small cell lung cancer: A United States–based cost‐effectiveness analysis

Xiaomin Wan, Xia Luo, Chongqing Tan et al. · Cancer · 2019 · 106 citations · Full text

Overexpression of Mitochondrial Phosphate Transporter 3 Severely Hampers Plant Development through Regulating Mitochondrial Function in Arabidopsis

Fengjuan Jia, Xiaomin Wan, Wei Zhu et al. · PLoS ONE · 2015 · 55 citations · Full text

, , +19

Cost–Utility Analysis of the Newly Recommended Adjuvant Chemotherapy for Resectable Gastric Cancer Patients in the 2011 Chinese National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology: Gastric Cancer

Chongqing Tan, Liubao Peng, Xiaohui Zeng et al. · PharmacoEconomics · 2013 · 51 citations

, , +9

Nivolumab Versus Docetaxel for Previously Treated Advanced Non-Small Cell Lung Cancer in China: A Cost-Effectiveness Analysis

Qiao Liu, Xia Luo, Liubao Peng et al. · Clinical Drug Investigation · 2019 · 47 citations · Full text

Rows per page

1–5 of 40